<DOC>
	<DOCNO>NCT00147524</DOCNO>
	<brief_summary>ACE inhibitor think modify endothelium number way . Quinapril effective well-tolerated ACE-I treatment patient hypertension congestive heart failure . Quinapril produce favourable haemodynamic change improve ventricular endothelial function patient various cardiovascular disorder . These effect mediate bind quinaprilat tissue plasma-ACE . Quinapril 10 40 mg daily improve endothelial function ( measure improve FMD reduce vasoconstrictive/increased vasodilative response Ach ) patient CAD hypertension 2 6 month therapy ; improve endothelial function also observe patient CHF receive single infusion quinaprilat . In general , quinapril show neutral beneficial effect lipid profile , glycaemia renal haemodynamics . ( 3 ) There data available consider effect quinapril endothelial dysfunction post- menopausal woman mild moderate hypertension pathological endothelial function .</brief_summary>
	<brief_title>Non-Comparative Study To Evaluate Changes In FMD After Quinapril Therapy In Hypertensive Women</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Quinapril</mesh_term>
	<criteria>pathological baseline FMD ( &lt; 5 % ) screen woman postmenopause least 2 year ( postmenopausal define amenorrhea Ã… 2 year ) mild moderate hypertension ( BP &gt; 140/90 mmHg ) uncontrolled severe hypertension ( BP &gt; 180/110 mmHg )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2007</verification_date>
</DOC>